Flouxetine for depression in diabetes: A randomized double-blind placebo-controlled trial

Diabetes Care

Volumn 23, Issue 5, 2000, Pages 618-623

  Lustman, Patrick J ^a,b   Freedland, Kenneth E ^a   Griffith, Linda S ^a   Clouse, Ray E ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOXETINE; ANTIDEPRESSANT AGENT; PLACEBO;

ADULT; ARTICLE; CLINICAL TRIAL; DEPRESSION; DIABETES MELLITUS; DRUG EFFICACY; GLUCOSE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; RATING SCALE; TREATMENT OUTCOME; AGED; BLOOD; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; INSULIN DEPENDENT DIABETES MELLITUS; METABOLISM; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; PSYCHOLOGICAL ASPECT; RANDOMIZED CONTROLLED TRIAL;

ADULT; AGED; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; BLOOD GLUCOSE; DEPRESSION; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; FLUOXETINE; HUMANS; MIDDLE AGED; PLACEBOS;

EID: 0033625510     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.23.5.618     Document Type: Article

References (52)

1. Gavard JA, Lustman PJ, Clouse RE: Prevalence of depression in adults with diabetes: an epidemiological evaluation. Diabetes Care 16:1167-1178, 1993
2. Lustman PJ, Velozo CA, Eubanks B, Montag JA, Cole DM: Effects of psychiatric disorder on rehabilitation efforts and ability to return to work following a job-related injury. Work 1:37-43, 1991
3. Styron W: Darkness Visible: A Memoir of Madness. New York, Random House, 1990
4. Wells KB, Stuart A, Hays RD, Burnam MA, Rogers W, Daniels M, Berry S, Greenfield S, Ware J: The functioning and well-being of depressed patients: results from the medical outcomes study. JAMA 262:914-919, 1989
5. Littlefield CH, Craven JL, Rodin GM, Daneman D, Murray MA, Rydall AC: Relationship of self-efficacy and bingeing to adherence to diabetes regimen among adolescents. Diabetes Care 15:90-94, 1992
6. McGill JB, Lustman PJ, Griffith LS, Freedland KE, Gavard JA, Clouse RE: Relationship of depression to compliance with self-monitoring of blood glucose (Abstract). Diabetes 41:A84, 1992
7. Lustman PJ, Griffith LS, Clouse RE, Cryer PE: Psychiatric illness in diabetes: relationship to symptoms and glucose control. J Nerv Ment Dis 174:736-742, 1986
8. Lustman PJ, Griffith LS, Clouse RE: Depression in adults with diabetes: results of a 5-yr follow-up study. Diabetes Care 11: 605-612, 1988
9. Friis R, Nanjundappa G: Diabetes, depression, and employment status. Soc Sci Med 23:471-475, 1986
10. Mazze RS, Lucido D, Shamoon H: Psychological and social correlates of glycemic control. Diabetes Care 7:360-366, 1984
11. Tun PA, Nathan DM, Perlmuter LC: Cognitive and affective disorders in elderly diabetics. Clin Geriatr Med 6:731-746, 1990
12. de Groot M, Jacobson AM, Samson JA: Psychiatric illness in patients with type I and type II diabetes mellitus (Abstract). Psychosom Med 56:176A, 1994
13. Van der Does FEE, De Neeling JND, Snock FJ, Kostense PJ, Grootenhuis PA, Bouter LM, Heine RJ: Symptoms and well-being in relation to glycemic control in type II diabetes. Diabetes Care 19:204-210, 1996
14. Sachs G, Spiess K, Moser G, Prager R, Kunz A, Schernthaner G: Glycosylated hemoglobin and diabetes self-monitoring (compliance) in depressed and nondepressed type I diabetics. Psychother Psychosom Med Psychol 41:306-312, 1991
15. Connell CM, Storandt M, Lichty W: Impact of health belief and diabetes-specific psychosocial context variables on self-care behavior, metabolic control and depression of older adults with diabetes. Behav Health Aging 1:183-196, 1990
16. Kovacs M, Mukerji P, Drash A, Iyengar S: Biomedical and psychiatric risk factors for retinopathy among children with IDDM. Diabetes Care 18:1592-1599, 1995
17. Carney RM, Rich MW, Freedland KE, Saini J, teVelde A, Simeone C, Clark K: Major depressive disorder predicts cardiac events in patients with coronary artery disease. Psychosom Med 50:627-633, 1988
18. Jacobson AM, Rand LI, Hauser ST: Psychologic stress and glycemic control: a comparison of patients with and without proliferative diabetic retinopathy. Psychosom Med 47:372-381, 1985
19. Lloyd C, Wilson R, Forrest K: Prior depressive symptoms and the onset of coronary heart disease (Abstract). Diabetes 46:13A, 1997
20. Lustman PJ, Griffith LS, Clouse RE, Freedland KE, Eisen SA, Rubin EH, Carney RM, McGill JB: Effects of nortriptyline on depression and glucose regulation in diabetes: results of a double-blind, placebo-controlled trial. Psychosom Med 59:241-250, 1997
21. Lustman PJ, Clouse RE, Freedland KE: Management of major depression in adults with diabetes: implications of recent clinical trials. Semin Clin Neuropsychiatry 3:102-114, 1998
22. Potter van Loon BJ, Radder JK, Frolich M, Krans HMJ, Zwinderman AH, Meinders AE: Fluoxetine increases insulin action in obese nondiabetic and in obese non-insulin-dependent diabetic individuals. Int J Obes 16:79-85, 1992
23. Gray DS, Fujioka K, Devine W, Bray GA: Fluoxetine treatment of the obese diabetic. Int J Obes 16:193-198, 1992
24. Stokes PL: Fluoxetine: a five-year review. Clin Ther 15:216-243, 1993
25. Cohn JB, Wilcox C: A comparison of fluoxetine, imipramine, and placebo in patients with major depressive disorder. J Clin Psychiatry 46:26-31, 1985
26. Stark P, Hardison CD: A review of multicenter controlled studies of fluoxetine vs. imipramine and placebo in outpatients with major depressive disorder. J Clin Psychiatry 46:53-58, 1985
27. Tollefson GD, Bosomworth JC, Heiligenstein JH, Potvin JH, Holman S, the Fluoxetine Collaborative Study Group: A double-blind, placebo-controlled clinical trial of fluoxetine in geriatric patients with major depression. Int Psychogeriatr 7:89-104, 1995
28. Robins LN, Helzer JE, Cottler LB, Goldring E: The Diagnostic Interview Schedule: Version III-R. St. Louis, MO, Washington University, 1989
29. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders. Washington, DC, American Psychiatric Association, 1987
30. Robins LN, Helzer JE, Croughan J, Williams JBW, Spitzer RL: The NIMH Diagnostic Interview Schedule: Version III. Washington, DC, U.S. Public Health Service, 1981
31. Lustman PJ, Harper GW, Griffith LS, Clouse RE: Use of the Diagnostic Interview Schedule in patients with diabetes. J Nerv Ment Dis 174:743-746, 1986
32. Lustman PJ, Freedland KE, Carney RM, Hong BA, Clouse RE: Similarity of depression in diabetic and psychiatric patients. Psychosom Med 54:602-611, 1992
33. Beck AT, Beamesderfer A: Assessment of depression: the depression inventory. Mod Probl Pharmacopsychiatry 7:151-169, 1974
34. Hamilton M: A rating scale for depression. J Neurol Neurosurg Psychiatry 23:56-62, 1960
35. Beck AT, Steer RA, Garbin MG: Psychometric properties of the Beck Depression Inventory: twenty-five years of evaluation. Clin Psychol Rev 8:77-100, 1988
36. Knesevich MA, Biggs JT, Clayton PJ, Ziegler VE: Validity of the Hamilton Rating Scale for Depression. Br J Psychiatry 131:49-52, 1977
37. Maier W, Heuser I, Philipp M, Frommberger U, Demuth W: Improving depression severity assessment. II. Content, concurrent and external validity of three observer depression scales. J Psychiatr Res 22:13-19, 1988
38. Miller IW, Bishop S, Norman WH, Maddever H: The modified Hamilton Rating Scale for Depression: reliability and validity Psychiatry Res 14:131-142, 1985
39. Potts MK, Daniels M, Burnam MA, Wells KB: A structured interview version of the Hamilton Depression Rating Scale: evidence of reliability and versatility of administration. J Psychiatr Res 24:335-350, 1990
40. Goldstein DE, Little RR, Lorenz RA, Malone JI, Nathan D, Peterson CM: Tests of glycemia in diabetes. Diabetes Care 18:896-909, 1995
41. Singer DE, Coley CM, Samet JH, Nathan DM: Tests of glycemia in diabetes mellitus: their uses in establishing a diagnosis and in treatment. Ann Intern Med 110:125-137, 1989
42. 10. Clin Chem 43: 511-517, 1997
43. Frank E, Karp JF, Rush AJ: Efficacy of treatments for major depression. Psychopharmacol Bull 29:457-475, 1993
44. Rush AJ, Prien RF: From scientific knowledge to the clinical practice of psychopharmacology: can the gap be bridged? Psychopharmacol Bull 31:7-20, 1995
45. Depression Guideline Panel: Depression in Primary Care: Vol. 2. Treatment of Major Depression. Rockville, MD, U.S. Dept. of Health and Human Services, 1997 (AHCPR publ. no. 93-0551)
46. Amsterdam JD, Fawcett J, Quitkin FM, Reimherr FW, Rosenbaum JF, Michelson D, Hornig-Rohan M, Beasley CM: Fluoxetine and norfluoxetine plasma concentrations in major depression: a multicenter study. Am J Psychiatry 154:963-969, 1997
47. Lustman PJ, Griffith LS, Freedland KE, Clouse RE: The course of major depression in diabetes. Gen Hosp Psychiatry 19:138-143, 1997
48. Paykel ES, Ramana R, Cooper Z, Hayhurst H, Kerr J, Barocka A: Residual symptoms after partial remission: an important outcome in depression. Psychol Med 25:1171-1180, 1995
49. Daubresse J-C, Kolanowski J, Krzentowski G. Kutnowski M, Scheen A, Van Gaal L: Usefulness of fluoxetine in obese non-insulin-dependent diabetics: a multicenter study. Obes Res 4:391-396, 1996
50. Maheux P, Ducros F, Bourque J, Garon J, Chiasson J-L: Fluoxetine improves insulin sensitivity in obese patients with non-insulin-dependent diabetes mellitus independently of weight loss. Int J Obes 21: 97-102, 1997
51. Lustman PJ, Griffith LS, Freedland KE, Kissel SS, Clouse RE: Cognitive behavior therapy for depression in type 2 diabetes: a randomized controlled trial. Ann Intern Med 129:613-621, 1998
52. Goldstein DE, Little RR, Wiedmeyer H, England JD, McKenzie EM: Glycated hemoglobin: methodologies and clinical applications. Clin Chem 32:B64-B70, 1986